JMP Securities Raises CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $80.00
CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its target price raised by JMP Securities from $74.00 to $80.00 in a report released on Monday, Benzinga reports. They currently have a market outperform rating on the stock. A number of other research firms also recently weighed in on CRSP. Truist Financial restated a buy rating on […]
More Stories
Applied Digital (NASDAQ:APLD) Sees Large Volume Increase – What’s Next?
Applied Digital Co. (NASDAQ:APLD – Get Free Report) shares saw strong trading volume on Monday . 9,305,650 shares changed hands...
Kinetik (NASDAQ:KNTK) Hits New 12-Month High – Still a Buy?
Kinetik Holdings Inc. (NASDAQ:KNTK – Get Free Report) shares hit a new 52-week high on Monday . The stock traded...
Maravai LifeSciences (NASDAQ:MRVI) Sets New 12-Month Low – Here’s What Happened
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) hit a new 52-week low during trading on Monday . The...
Fidus Investment (NASDAQ:FDUS) Sets New 1-Year High – Here’s What Happened
Fidus Investment Co. (NASDAQ:FDUS – Get Free Report) reached a new 52-week high during trading on Monday . The company...
Celsius (NASDAQ:CELH) Shares Down 0.7% – Time to Sell?
Celsius Holdings, Inc. (NASDAQ:CELH – Get Free Report)’s share price was down 0.7% during mid-day trading on Monday . The...
Inhibrx, Inc. (NASDAQ:INBX) Short Interest Update
Inhibrx, Inc. (NASDAQ:INBX – Get Free Report) was the recipient of a large increase in short interest during the month...